Authors: | Holstein, S. A.; Asimakopoulos, F.; Azab, A. K.; Bianchi, G.; Bhutani, M.; Crews, L. A.; Cupedo, T.; Giles, H.; Gooding, S.; Hillengass, J.; John, L.; Kaiser, S.; Lee, L.; Maclachlan, K.; Pasquini, M. C.; Pichiorri, F.; Shah, N.; Shokeen, M.; Shy, B. R.; Smith, E. L.; Verona, R.; Usmani, S. Z.; McCarthy, P. L. |
Title: | Proceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Immune and Cellular Therapy in Multiple Myeloma |
Abstract: | The Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Myeloma Intergroup conducted a workshop on Immune and Cellular Therapy in Multiple Myeloma on January 7, 2022. This workshop included presentations by basic, translational, and clinical researchers with expertise in plasma cell dyscrasias. Four main topics were discussed: platforms for myeloma disease evaluation, insights into pathophysiology, therapeutic target and resistance mechanisms, and cellular therapy for multiple myeloma. Here we provide a comprehensive summary of these workshop presentations. © 2022 The American Society for Transplantation and Cellular Therapy |
Keywords: | pathogenesis; conference paper; cancer immunotherapy; multiple myeloma; bone marrow; cancer research; cancer resistance; cell therapy; imaging; biological therapy; bone marrow transplantation; resistance; tumor microenvironment; workshop; plasma cell dyscrasia; high throughput sequencing; humans; human; cell- and tissue-based therapy; car t cell |
Journal Title: | Transplantation and Cellular Therapy |
Volume: | 28 |
Issue: | 8 |
ISSN: | 2666-6375 |
Publisher: | Elsevier Inc. |
Date Published: | 2022-08-01 |
Start Page: | 446 |
End Page: | 454 |
Language: | English |
DOI: | 10.1016/j.jtct.2022.05.019 |
PUBMED: | 35605882 |
PROVIDER: | scopus |
PMCID: | PMC9357156 |
DOI/URL: | |
Notes: | Conference Paper -- Export Date: 2 September 2022 -- Source: Scopus |